Needle-Free
Intradermal
Oncology
Infectious Disease
Global Impact
Resources
Press Coverage
News Releases
Publications
FAQs
Our Blogs
Events
Presentations
About
About Pharmajet
Partner With Us
Contact
Publications
All Categories
Clinical Studies (36)
Pre-Clinical Studies (23)
All Tags
Adjuvants (1)
ANDV (3)
Arboviruses (10)
Atherosclerosis (1)
Cancer (3)
Clinical (2)
COVID-19 (10)
Cow (3)
Dengue (5)
DNA (24)
DOBV (1)
Equine Influenza (1)
Hamster (2)
Hantaviruses (5)
Hepatitis B (1)
HIV (1)
HNTV (1)
Horse (1)
HPV (1)
HTNV (1)
Improved Performance (14)
Inactivated (14)
Infectious Diseases (1)
Influenza (5)
Live Attenuated (7)
Lymphoma (1)
Mice (1)
MMR (3)
Mouse (2)
mRNA (2)
Nanoparticle (1)
Non-Human (1)
Non-Human Primate (10)
Other Applications (2)
Other Viruses (9)
Pentavalent (1)
Phase 1 (6)
Phase 1/2 (3)
Phase 1b (1)
Phase 2 (2)
Phase 2/3 (1)
Phase 3 (2)
Phase 3/4 (1)
Phase 4 (3)
Pig (5)
Polio (14)
Pox (3)
Protein Subunit (2)
PRRSV (1)
PUUV (2)
Rabbit (4)
Rabies (3)
Respiratory Viruses (12)
RNA (3)
SEOV (1)
SNV (2)
Stratis (27)
Tropis (38)
Tropis/Stratis (7)
VEEV (2)
Zika (6)
Reset
A Narrative Review and Perspective on Implementation Research on Intradermal Delivery Methods for Fractionated-Dose Inactivated Poliomyelitis Vaccine
2026
Backunawa, GB et al
Tags:
Polio
,
Tropis
View
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination
2026
Frey, S et al
Tags:
Rabies
,
Tropis
View
Evaluating the Impact of Needle-Free Delivery of Inactivated Polio Vaccine on Nigeria’s Routine Immunization Program: An Implementation Hybrid Trial
2025
Mohan, D et al
Tags:
Polio
,
Tropis
View
Tropis needle-free injector for fractional-dose IPV administration: A pilot study for integration into routine immunization services in Cuba
2025
Resik, S et al
Tags:
Inactivated
,
Polio
,
Tropis
View
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19
2025
Kumar, D et al
Tags:
COVID-19
,
mRNA
,
Phase 3
,
Tropis
View
Use of a fractional dose of inactivated polio vaccine (fIPV) to increase IPV coverage among children under 5 years of age in Somalia
2024
Nouh, K et al
Tags:
Inactivated
,
Polio
,
Tropis
View
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
2024
Saraf, A
Tags:
COVID-19
,
mRNA
,
Phase 2/3
,
Tropis
View
Notes from the Field: House-to-House Campaign Administration of Inactivated Poliovirus Vaccine — Sokoto State, Nigeria, November 2022
2023
Biya, O et al
Tags:
Polio
,
Tropis
View
Improved DNA Vaccine Delivery with Needle-Free Injection Systems
2022
Ledesma-Feliciano, C
Tags:
COVID-19
,
Dengue
,
DNA
,
Hantaviruses
,
HIV
,
Influenza
,
Pox
,
Tropis/Stratis
,
VEEV
,
Zika
View
A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challenge
2022
Suschak, J
Tags:
Clinical
,
DNA
,
Infectious Diseases
,
Non-Human
,
Stratis
,
Tropis
,
VEEV
View
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
2022
Khobragade, A
Tags:
Clinical
,
DNA
,
Phase 3
,
Respiratory Viruses
,
Tropis
View
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
2022
Houser, KV
Tags:
Improved Performance
,
Influenza
,
Phase 1
,
Stratis
View
1
2
3
…
5
»
Menu